Cranberry proanthocyanidins inhibit MMP production and activity

V D La1, A B Howell, D Grenier

  • 1Groupe de Recherche en Ecologie Buccale, Faculté de Médecine Dentaire, Université Laval, 2420 Rue de Terrasse, Quebec City, QC, Canada G1V 0A6.

Insights

A-type cranberry proanthocyanidins (AC-PACs) inhibit matrix metalloproteinases (MMPs) linked to periodontal disease. These compounds reduce MMP production and activity, offering potential for new treatments against tissue destruction.

Area of Science:

  • Periodontology
  • Immunology
  • Natural Products Chemistry

Background:

  • Matrix metalloproteinases (MMPs) are key mediators of periodontal tissue destruction, often produced by inflammatory cells in response to pathogens.
  • Understanding host-modulating strategies is crucial for managing periodontitis and preventing tissue damage.

Purpose of the Study:

  • To investigate the effects of A-type cranberry proanthocyanidins (AC-PACs) on MMP production and activity in macrophages stimulated by Aggregatibacter actinomycetemcomitans lipopolysaccharide (LPS).
  • To explore the impact of AC-PACs on intracellular signaling pathways, including protein kinases and nuclear factor-kappa B (NF-kappaB) p65 activity.

Main Methods:

  • Human monocyte-derived macrophages were stimulated with LPS to induce MMP production.
  • The effects of varying concentrations of AC-PACs on MMP production, catalytic activity (MMP-1, MMP-9), protein kinase phosphorylation, and NF-kappaB p65 activity were assessed.

Main Results:

  • AC-PACs demonstrated a concentration-dependent inhibition of MMP production by macrophages.
  • The catalytic activity of recombinant MMP-1 and MMP-9 was significantly inhibited by AC-PACs.
  • Inhibition of MMPs correlated with reduced phosphorylation of key intracellular kinases and decreased NF-kappaB p65 activity.

Conclusions:

  • AC-PACs effectively inhibit MMP production and activity, suggesting a role in mitigating periodontal tissue destruction.
  • The findings highlight the potential of AC-PACs as a novel host-modulating agent for periodontitis treatment.
  • AC-PACs may offer a therapeutic strategy by targeting MMP-mediated pathways involved in inflammatory tissue damage.